Thus HOXD10 and D11, consistently highly expressed in HNSCC cell lines, macro-dissected tumor tissue samples, and in publicly available tissue microarray data from patients with HNSCC, were selected as candidate genes for further study. This evidence concerns the gene HOXD10 and head and neck squamous cell carcinoma.